Skip to main content
. 2018 May 14;113(6):e170489. doi: 10.1590/0074-02760170489

TABLE V. Analysis of single nucleotide polymorphisms located in the TNFR1 and TNFR2 cluster.

Stage A
N= 110
Stage B1
N= 163
Stage C
N= 133
A versus B1 A versus C B1 versus C A versus B1+C
ORa [95% CI] p-value ORa [95% CI] p-value ORa [95% CI] p-value ORa [95% CI] p-value
TNFR1 +36 A > G rs767455
GG 47 (0.52) 66 (0.48) 46 (0.40) Reference
AG 36 (0.40) 58 (0.42) 56 (0.49) 1.1 [0.6-2.0] 0.86 1.6 [0.9-2.8] 0.24 1.3 [0.8-2.2] 0.58 1.3 [0.8-2.2] 0.44
AA 8 (0.08) 13 (0.10) 13(0.11) 1.2 [0.5-3.3] 1.8 [0.7-4.7] 1.3 [0.5-3.2] 1.5 [0.6-3.5]
A carriers 44 (0.48) 71 (0.52) 69 (0.60) 1.2 [0.7-2.0] 0.60 1.6 [0.9-2.8] 0.09 1.3 [0.8-2.2] 0.30 1.4 [0.8-2.2] 0.21
TNFR2+1466 A > G rs1061624
AA 25 (0.27) 32 (0.23) 36 (0.32) Reference
AG 49 (0.53) 72 (0.53) 53 (0.46) 1.1 [0.6-2.2] 0.80 0.8 [0.4-1.5] 0.63 0.7 [0.4-1.2] 0.43 0.9 [0.5-1.6] 0.78
GG 18 (0.20) 33 (0.24) 25 (0.22) 1.3 [0.6-3.0] 1.0 [0.4-2.2] 0.7 [0.4-1.5] 1.2 [0.6-2.4]
G carriers 67 (0.73) 105 (0.77) 78 (0.68) 1.2 [0.6-2.2] 0.59 0.8 [0.4-1.5] 0.54 0.7 [0.4-1.2] 0.20 1.0 [0.6-1.7] 0.99
a

odds ratio (OR) values shown are corrected for gender and ethnicity; results are shown as n (frequency); CI: confidence interval; total genotype counts can vary due to different genotypic call rates.